Washington DC [USA], June 8 (ANI): The US government's current supply of Remdesivir, the only drug till now known to be working against coronavirus, will exhaust by the end of June.
New Delhi [India], June 8 (ANI): The Union Health Ministry has drafted the new rules for import of unapproved new drug for only 'compassionate Use' for treatment of patients by hospitals or medical institutions under New Drugs and Clinical Trials Rules, 2019.
Mumbai (Maharashtra) [India], June 6 (ANI): Maharashtra Health Minister Rajesh Tope on Saturday said that the state will procure 10,000 vials of Remdesivir drug.
New Delhi [India], June 6 (ANI): After a gap of five years, actor Sushmita Sen has made a thrilling comeback with the captivating trailer of her debut web series 'Aarya', which is all set to air on June 19.
New Delhi [India], June 6 (ANI): Clinical trials of the plant-derived drug, ACQH, to treat COVID-19 patients that began on Friday in India has been hailed by the Council of Scientific and Industrial Research (CSIR) as "historic in modern medicine".
Mumbai (Maharashtra) [India], June 5 (ANI): Sun Pharmaceutical Industries has started phase two clinical trial on AQCH, a phytopharmaceutical (plant-derived) drug for the treatment of COVID-19.
Washington D.C. [USA], June 5 (ANI): Three authors involved in a Lancet article that drew scrutiny over the trial of the antimalarial drug-- hydroxychloroquine-- for curing patients infected with COVID-19 said they retracted items related to it over unavailability of full data set behind the
New Delhi [India], June 4 (ANI): As many as 90 companies and experts attended an interaction held under the chairmanship of Principal Secretary, Industries, A K Singh in the presence of MD, HSIIDC, Anurag Agarwal regarding setting up of bulk drugs park over an area of about 650 acres in Indu
New Delhi [India], June 4 (ANI): Former honorary physician to the President of India and senior physician at Ganga Ram hospital Dr Mohsin Wali has welcomed the move of the Drug Controller General of India to give permission for emergency use of Remdesivir to treat COVID-19 patients and sa
New Delhi [India], June 4 (ANI): Two domestic pharmaceutical firms--Mylan and Jubilant Life Sciences have approached the country's top drug regulator--Drug Controller General of India (DCGI) to seek its approval to manufacture and sell anti-viral drug 'Remdesivir' in India to combat COVID-19
New Delhi [India], June 4 (ANI): CSIR Director-General Shekhar Mande said on Thursday that the World Health Organisation's (WHO) decision to halt hydroxychloroquine (HCQ) drug trial was taken in haste and the global body should have actually analysed the data before making the decision.
Srinagar (Jammu and Kashmir) [India], June 3 (ANI): The District Administration in Srinagar has assisted over 7000 non-Covid health emergencies and ailment cases, with assistance ranging from free dialysis, transportation, drugs, medical check-ups, hospital assistance, chemotherapies and oth